Life Science Angels logo

Life Science Angels

North America, California, United States, Sunnyvale

Description

Life Science Angels (LSA) is a prominent angel investment group based in Sunnyvale, California, dedicated to funding early-stage life science companies. Established as a not-for-profit organization, LSA comprises accredited angel investors with deep expertise across various sectors, including biotechnology, medical devices, diagnostics, and digital health. Their primary mission is to provide crucial seed and Series A capital to innovative startups poised to make significant impacts in healthcare.

LSA typically targets companies that are beyond the concept stage, possessing a strong management team, a clear intellectual property strategy, and a well-defined path to market. The group's investment strategy often involves participating in syndicates, leveraging their network to co-invest alongside other angel groups, venture capital firms, and strategic partners. Their typical first check size ranges from $250,000 to $1,000,000, reflecting their commitment to providing meaningful early-stage capital.

Since its inception, Life Science Angels has established itself as one of the most active angel groups in the life science sector. The organization boasts a robust track record, having invested over $100 million into more than 100 companies. Beyond financial capital, LSA provides significant value through the collective expertise of its over 100 members, who offer mentorship, strategic guidance, and access to extensive industry networks, helping portfolio companies navigate the complex landscape of life science development and commercialization.

Investor Profile

Life Science Angels has backed more than 83 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 10% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Israel, The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Typical check size: $250K – $1M.

Stage Focus

  • Seed (34%)
  • Series Unknown (28%)
  • Series A (23%)
  • Series B (11%)
  • Angel (2%)
  • Series C (2%)

Country Focus

  • United States (98%)
  • Israel (1%)
  • The Netherlands (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Life Science
  • Therapeutics
  • Software
  • Manufacturing
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Life Science Angels frequently co-invest with?

Band of Angels
North America, California, United States, Menlo Park
Co-Investments: 5
Sidecar Angels
North America, Massachusetts, United States, Somerville
Co-Investments: 4
LaunchCapital
North America, Connecticut, United States, New Haven
Co-Investments: 4
Sand Hill Angels
North America, California, United States, Mountain View
Co-Investments: 9
Berkeley Angel Network
North America, California, United States, San Francisco
Co-Investments: 4
The Angels' Forum
North America, California, United States, Mountain View
Co-Investments: 4
Keiretsu Forum
North America, California, United States, Orinda
Co-Investments: 3
Tech Coast Angels
North America, California, United States, Newport Beach
Co-Investments: 13
Mass Medical Angels
North America, Massachusetts, United States, Boston
Co-Investments: 3
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 3

Which angels does Life Science Angels often collaborate with?

Shared Deals: 1
DH
North America, New York, United States, New York
Shared Deals: 1
Shared Deals: 1
NS
North America, Iowa, United States, Des Moines
Shared Deals: 1
SK
North America, California, United States, San Francisco
Shared Deals: 1
ND
North America, California, United States, San Francisco
Shared Deals: 1
GB
North America, Massachusetts, United States, Boston
Shared Deals: 1
MF
North America, California, United States, San Francisco
Shared Deals: 1
CS
North America, California, United States, Palo Alto
Shared Deals: 1
David Wu
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Life Science Angels?

Journey Live

New York, New York, United States

Journey Live offers a preventative mental health solution to reduce turnover, tackle burnout, and help employees live healthier lives.

FitnessHealth CareMental HealthWellness
Series AJul 25, 2025
Amount Raised: $8,000,000
Trio Pharmaceuticals

San Diego, California, United States

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.

BiotechnologyHealth CareMedicalTherapeutics
SeedDec 3, 2024
Amount Raised: $3,100,000
Flyte

Minneapolis, Minnesota, United States

Flyte is a femtech company that specializes in developing solutions to cure bladder leaks.

Health CareMedicalWomen's
SeedApr 22, 2024
Amount Raised: $2,320,000
Neurava

West Lafayette, Indiana, United States

Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.

Health CareHealth DiagnosticsMedical Device
SeedApr 3, 2024
Amount Raised: $2,260,000
Averto Medical

Belmont, California, United States

Averto Medical is a medical device manufacturing company.

Health CareManufacturingMedical Device
Series UnknownNov 28, 2023
Amount Raised: $3,000,000
Avisi Technologies

Redwood City, California, United States

Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.

Health CareMedical DeviceNanotechnology
SeedOct 1, 2023
Amount Raised: $6,334,000
Astrocyte Pharmaceuticals

Cambridge, Massachusetts, United States

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
Series BAug 18, 2023
Amount Raised: $6,000,000
InnoSIGN

Eindhoven, Noord-Brabant, The Netherlands

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.

BiotechnologyLife ScienceMedicalPrecision Medicine
Series AMar 22, 2022
Amount Raised: $8,084,529
Avisi Technologies

Redwood City, California, United States

Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.

Health CareMedical DeviceNanotechnology
SeedSep 1, 2021
Amount Raised: $1,488,000
Allyx Therapeutics

New Haven, Connecticut, United States

Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.

BiotechnologyHealth CareLife ScienceMedical
Series AJun 1, 2021
Amount Raised: $7,581,493